|
Delayed
Nasdaq
01:30:00 15/08/2025 am IST
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 332.12Cr 286.19Cr 268.33Cr 244.95Cr 461.44Cr 32TCr 462.91Cr 3.18TCr 1.24TCr 16TCr 1.25TCr 1.22TCr 53TCr | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 347.73Cr 299.64Cr 280.94Cr 256.46Cr 483.13Cr 33TCr 484.66Cr 3.33TCr 1.3TCr 17TCr 1.31TCr 1.28TCr 56TCr | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 30/25/30 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 30/25/30 | Amedisys: Q2 Earnings Snapshot | AQ |
| 30/25/30 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 30/25/30 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 24/25/24 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 3 years | 82.15 |  | 101.02 |
| 5 years | 69.36 | | 188.88 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 06/10/2017 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 14/08/25 | Issuer sale | Chief Executive Officer | 5,20,347 | 1.5886% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 223.64Cr 192.71Cr 180.68Cr 164.94Cr 310.72Cr 21TCr 311.71Cr 2.14TCr 836.38Cr 11TCr 839.65Cr 821.38Cr 36TCr | 234.83Cr 202.36Cr 189.73Cr 173.19Cr 326.27Cr 22TCr 327.31Cr 2.25TCr 878.25Cr 11TCr 881.68Cr 862.49Cr 38TCr |
| Net income | -97.47L -83.99L -78.75L -71.89L -1.35Cr -93Cr -1.36Cr -9.34Cr -3.65Cr -47Cr -3.66Cr -3.58Cr -155.93Cr | 4.32Cr 3.73Cr 3.49Cr 3.19Cr 6.01Cr 413.18Cr 6.03Cr 41Cr 16Cr 208.57Cr 16Cr 16Cr 691.58Cr |
| Net Debt | 36Cr 31Cr 29Cr 27Cr 50Cr 3.45TCr 50Cr 345.81Cr 134.92Cr 1.74TCr 135.45Cr 132.5Cr 5.77TCr | 16Cr 13Cr 13Cr 12Cr 22Cr 1.49TCr 22Cr 149.59Cr 58Cr 752.91Cr 59Cr 57Cr 2.5TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
